Type of treatment | Anti-VEGF | TA | DEX | |
---|---|---|---|---|
Number of eyes | 5 | 7 | 4 | |
Number of Injections (Median; [Range]) | 2.5, 1-14 | 2.0, 1-10 | 2.5, 1-7 | |
CST pre-injection (μm) | 401 ± 84.9 | 481 ± 104 | 397 ± 57.0 | P = 0.397 |
CST post-injection (μm) | 393 ± 106 | 402 ± 102 | 355 ± 80.4 | |
Percent CST change (μm) | − 1.44 ± 17.1, P = 0.915 | − 15.6 ± 16.6, P = 0.016 | − 11.0 ± 10.7, P = 0.434 | |
Inner macular volume pre-injection (mm3) | 2.81 ± 0.43 | 3.18 ± 0.56 | 3.12 ± 0.80 | P = 0.457 |
Inner macular volume post-injection (mm3) | 2.74 ± 0.53 | 2.72 ± 0.53 | 2.66 ± 0.486 | |
Percent (%) inner macular volume change (mm3) | −2.49 ± 12.35, P = 0.828 | −13.9 ± 10.8, P = 0.016 | −10.7 ± 25.7, P = 0.125 |